Takeda Pharmaceuticals and Actos®
Takeda Pharmaceuticals has a long, rich history that goes back hundreds of years but its history of lawsuits is happening right now. All in all, this is why Daviagra overnight dangerous products medical attorneys legal firms and lawyers have been active as of late with various complaints concerning Depakote, Actos, Plavix, Topamax and the like. Takeda was originally founded in Osaka, Japan in 1781. Though it wasn’t known as Takeda Pharmaceuticals then, it was just a single medicine shop. It began importing Western medicine in 1871 and built its first manufacturing facility in 1895. Back then, it was known as Chobei Takeda & Company Limited, and by 1925 it held a net worth of about one million dollars.
Following World War II, Takeda’s primary products included penicillin and B1 vitamin. It became a publicly traded company by 1949 and, until 1970, grew as much as 20% each year. In 1985, Takeda released a new cancer-fighting drug, Lupron, in the United States. With Lupron Depot (a successor of Lupron) and Prevacid, Takeda found itself expanding into both American and European markets. Needless to say, various Dangerous products medical attorneys and related law firms have ben busy with these civil court cases and proceedings.
Takeda Pharmaceuticals began to turn its focus to Actos® in 1999. Just two years later, Actos® alone was earning Takeda Pharmaceuticals nearly half of the company’s yearly net sales. But the focus soon began to shift as new research into Actos® showed an increased risk of serious, life-changing side effects, particularly for patients who took Actos® for long periods of time. The most common of the side effects linked to Actos® are an increased risk of bladder cancer and also congestive heart failure.